Quantcast

Endometrial Myomectomy; A Novel Surgical Method during Cesarean Section.

Research paper by Şafak Ş Hatırnaz, Oğuz O Güler, Serdar S Başaranoğlu, Cengiz C Tokgöz, Gökhan Sami GS Kılıç

Indexed on: 25 Jan '17Published on: 25 Jan '17Published in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians



Abstract

Comparing surgical outcomes of a novel surgical technique Endometrial Myomectomy (EM) to serosal myomectomy (SM) during Ceserean Section (CS).Retrospective cohort study(Canadian task force classification level II 1) Setting: Private Hospital Patients: Fourty six women with leiomyomas during cesarean section Interventions: Endometrial myomectomy and serosal myomectomy during cesarean section between 2013 and 2016.Total 22 consequtive cases (Group 1) underwent EM in the last 2 years. Control group created from SM (Group 2) cases performed before EM implemented in our practice. Group 2 was matched based on anteriorly located intramural or submucosal leiomyoma. The size, location and number of leiomyoma, hematological course during pre- and postoperative period, the need for blood transfusion, duration of surgery and any prolongation of hospital stay also documented.Median number of leiomyoma was higher in EM than in SM (p = 0.001). Median myomectomy procedure time and amount of intra operative bleeding in SM were higher than EM (respectively p = 0.005 and p = 0.001).In terms of other variables, there is no difference between the two myomectomy groups (p > 0.05).This novel technique EM is a safe, feasible surgical technique compare to SM. Besides the less intra operative blood loss, it also has potential to diminish the risk of abdominal adhesion formation.

More like this: